Revenue: Not applicable/not reported for QQ1 2026. YoY/QoQ revenue data is not available.
Gross Profit: -$2,000 (cost of revenue $2,000 with no associated revenue).
Operating Income: -$3.090 million for QQ1 2026; YoY growth estimated at 5.30% vs prior period, QoQ growth of 16.58% per disclosed metrics, reflecting modest sequential improvement in operating loss as some cost bases evolve.
EBITDA: -$3.360 million; EBITDA margin not meaningful given no revenue.
Net Income: -$3.362 million; YoY change -6.19%, QoQ change +19.09% (reflecting a tighter loss vs the prior quarter on a net basis).
EPS (Diluted): -$0.21; YoY +38.24%, QoQ +41.67%.
Cash Flow: Net cash used in operating activities -$1.801 million; Free cash flow -$1.801 million.
Liquidity: Cash and cash equivalents $20.005 million; Net debt = -$20.005 million (net cash position).
Balance Sheet Health: Total assets $69.805 million; total liabilities $6.255 million; total stockholders’ equity $63.550 million. Intangibles and goodwill amount to $49.266 million, constituting ~70% of total assets, indicating a pipeline- or acquisition-derived asset base with impairment risk potential.
Capital Structure: No long-term debt reported; net cash position provides runway for continued R&D investment given current burn rates.